Jordan happiness feelings fears career action Jordan

Stop Working and Take Your Lunch Breaks—Your Career Will Thank You

Reading now: 698
success.com

of hybrid or fully remote models of work, many may decide against taking a break to eat. So if you tend to eat a salad at your desk with your head down, here are some reasons taking time out of your day to break for lunch can actually benefit your career.According to conducted by ezCater, 78% of workers feel that having a lunch break improves their productivity at work.

Yet, “1 in 10 employees never take a break away from their desks—and 70% eat while they work at least once a week,” along with 43% of workers who eat at their desks at least three times a week.

Jordan McDonnell, a St. Louis-based transaction coordinator, is among those who sometimes work through lunch.“It’s nice to be able to get more work done,” she says.

Read more on success.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

additudemag.com
56%
686
LSD, MDMA, Magic Mushrooms Clinical Trial Guidelines Released by FDA
July 7, 2023The Food and Drug Administration (FDA) has issued its first-ever draft guidance for clinical trials of psychedelic drugs to treat conditions including depression, mood disorders, anxiety, post-traumatic stress disorder, and substance use disorder.The guidance aims to address the unique challenges inherent in testing “classic psychedelics,” such as psilocybin (magic mushrooms) and lysergic acid diethylamide (LSD), and “entactogens” or “empathogens,” such as methylenedioxymethamphetamine (MDMA) for treating psychiatric conditions that failed to respond to other therapies. The FDA recommends clinical trial considerations regarding subject safety, data collection, manufacturing controls, and drug application requirements.Ultimately, “the goal is to help researchers design studies that will yield interpretable results that will be capable of supporting future drug applications,” said Tiffany Farchione, M.D., director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research, in a statement last month.In February 2022, researchers from Johns Hopkins Medicine reported that psilocybin-assisted therapy for major depressive disorder produced antidepressant effects up to 12 months after treatment.1Ari Tuckman, Psy.D., and Stephanie Sarkis, Ph.D., recently told ADDitude that using very low (micro) doses of psychedelics, such as LSD and psilocybin is gaining renewed attention as a treatment for anxiety and depression.
DMCA